Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis
| Status: | Completed |
|---|---|
| Conditions: | Psoriasis, Dermatology, Dermatology, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 12/9/2018 |
| Start Date: | September 4, 2015 |
| End Date: | August 29, 2017 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Moderate to Severe Atopic Dermatitis.
Efficacy and Safety of DSXS (Taro Pharmaceuticals, U.S.A., Inc.) in Patients with Moderate to
Severe Atopic Dermatitis
Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study
to Evaluate the Efficacy and Safety of DSXS (Taro Pharmaceuticals, U.S.A., Inc.) in Patients
with Moderate to Severe Atopic Dermatitis
to Evaluate the Efficacy and Safety of DSXS (Taro Pharmaceuticals, U.S.A., Inc.) in Patients
with Moderate to Severe Atopic Dermatitis
Inclusion Criteria:
- male and non-pregnant females, age 6 months or older, with a confirmed diagnosis of
moderate to severe atopic dermatitis (AD)
Exclusion Criteria:
- Lacks stable diagnosis of atopic dermatitis or has been diagnosed with mild atopic
dermatitis.
We found this trial at
1
site
Click here to add this to my saved trials
